Company Filing History:
Years Active: 2016
Title: Scott Borella: Innovator in Antiproliferative Compounds
Introduction
Scott Borella is a notable inventor based in Charlotte, NC (US). He has made significant contributions to the field of medical research, particularly in the development of compounds that can aid in the treatment of diseases characterized by abnormal cell proliferation.
Latest Patents
Scott Borella holds a patent for "Low calcemic, highly antiproliferative, analogs of calcitriol." This patent provides compounds, compositions, and methods that utilize these compounds to stimulate the differentiation of cells and inhibit excessive cell proliferation, including cancer cells and skin cells. His work is particularly relevant for treating conditions such as leukemia, myelofibrosis, and psoriasis, without the adverse effects on calcium metabolism that can lead to hypercalcemia. He has 1 patent to his name.
Career Highlights
Scott Borella is affiliated with Johns Hopkins University, where he continues to engage in innovative research. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
Some of his notable coworkers include Gary H Posner and Kimberly S Petersen, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Scott Borella's innovative work in developing antiproliferative compounds showcases his commitment to advancing medical science. His contributions are vital for improving treatment options for patients with serious health conditions.